TP53 and primary effusion lymphoma: Chudasama et al. [32] in 2015 reported that p53 signalling remains intact in primary effusion lymphoma (PEL) cells in response to p53-activating agents, thus concluding that HHV8 genes do not inhibit the p53 protein.